tirzepatide for osa and Semaglutide: Impact on in Obesity 🚨‼️Study presented at @AmDiabetesAssn 🔴Tirzepatide
Description
PMC 3702070
10.2337/dc20-1815 [DOI] [PMC free article] [PubMed] 172.He L, Wang J, Ping F, et al
Ideal candidates include adults with: BMI 30 (obesity) BMI 27 with weight-related conditions (type 2 diabetes, hypertension, high cholesterol, sleep apnea, PCOS) Inability to lose weight through diet and exercise alone Contraindications include: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN 2) History of pancreatitis (caution advised) Your online doctor will evaluate all risks and benefits before prescribing
The mean age of adult patients was 58 years, 4% were 75 years or older and 54% were male
